Review of New American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
https://doi.org/10.18087/cardio.2018.11.10201
Abstract
In this brief review we focus on major updates and key points of 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
About the Authors
N. Yu. Mironov
Russian Cardiology Research Center
Russian Federation
Russian Federation
Mironov Nicolay Yu. - PhD., Department of clinical electrophysiology.
Moscow
S. P. Golitsyn
Russian Cardiology Research Center
Russian Federation
Russian Federation
Golitsyn Sergey P. - MD, professor, Department of clinical electrophysiology.
Moscow
References
1. Al-Khatib S. M., Stevenson W. G., Ackerman M.J. et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2017; pii: S0735-1097 (17) 41305-2.
2. Zipes D. P., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report ofthe American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48 (5):e247-346.
3. Priori S. G., Blomstrom-Lundqvist C., Mazzanti A. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36 (41):2793-2867.
4. Wilkoff B. L., Fauchier L., Stiles M. K. et al. 2015 HRS/EHRA/ APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28.
5. Kober L., Thune J.J., Nielsen J. C. et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221-1230.
6. Golwala H., Bajaj N. S., Arora G. et al. Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated metaanalysis. Circulation 2017;135:201-203.
7. Anderson J. L., Heidenreich P. A., Barnett P. G. et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2304-2322.
Review
For citations:
Mironov N.Yu., Golitsyn S.P. Review of New American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Kardiologiia. 2018;58(11):94-100. (In Russ.) https://doi.org/10.18087/cardio.2018.11.10201
Views:
6931
Email this article 
Post a Comment 
